Global Metabolic Biomarker Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR112403751

Publication Date:

November 28, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Metabolic Biomarker Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.
The report includes an overview of the development of the Metabolic Biomarker Testing industry chain, the market status of Drug Discovery (Separation Techniques, Detection Techniques), Nutrigenomics (Separation Techniques, Detection Techniques), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Metabolic Biomarker Testing.
Regionally, the report analyzes the Metabolic Biomarker Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Metabolic Biomarker Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Metabolic Biomarker Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Metabolic Biomarker Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Technology (e.g., Separation Techniques, Detection Techniques).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Metabolic Biomarker Testing market.
Regional Analysis: The report involves examining the Metabolic Biomarker Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Metabolic Biomarker Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Metabolic Biomarker Testing:
Company Analysis: Report covers individual Metabolic Biomarker Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Metabolic Biomarker Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug Discovery, Nutrigenomics).
Technology Analysis: Report covers specific technologies relevant to Metabolic Biomarker Testing. It assesses the current state, advancements, and potential future developments in Metabolic Biomarker Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Metabolic Biomarker Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Metabolic Biomarker Testing market is split by Technology and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Technology, and by Application in terms of value.
Market segment by Technology
Separation Techniques
Detection Techniques
Others
Market segment by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Others
Market segment by players, this report covers
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Metabolic Biomarker Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Metabolic Biomarker Testing, with revenue, gross margin and global market share of Metabolic Biomarker Testing from 2019 to 2024.
Chapter 3, the Metabolic Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Technology and application, with consumption value and growth rate by Technology, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Metabolic Biomarker Testing market forecast, by regions, technology and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metabolic Biomarker Testing.
Chapter 13, to describe Metabolic Biomarker Testing research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of Metabolic Biomarker Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Metabolic Biomarker Testing by Technology
1.3.1 Overview: Global Metabolic Biomarker Testing Market Size by Technology: 2019 Versus 2023 Versus 2030
1.3.2 Global Metabolic Biomarker Testing Consumption Value Market Share by Technology in 2023
1.3.3 Separation Techniques
1.3.4 Detection Techniques
1.3.5 Others
1.4 Global Metabolic Biomarker Testing Market by Application
1.4.1 Overview: Global Metabolic Biomarker Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Drug Discovery
1.4.3 Nutrigenomics
1.4.4 Toxicology Testing
1.4.5 Personalized Medicine
1.4.6 Functional Genomics
1.4.7 Others
1.5 Global Metabolic Biomarker Testing Market Size & Forecast
1.6 Global Metabolic Biomarker Testing Market Size and Forecast by Region
1.6.1 Global Metabolic Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Metabolic Biomarker Testing Market Size by Region, (2019-2030)
1.6.3 North America Metabolic Biomarker Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Metabolic Biomarker Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Metabolic Biomarker Testing Market Size and Prospect (2019-2030)
1.6.6 South America Metabolic Biomarker Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Metabolic Biomarker Testing Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Metabolic Biomarker Testing Product and Solutions
2.1.4 Agilent Technologies Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Product and Solutions
2.2.4 Bio-Rad Laboratories Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.3 Bruker
2.3.1 Bruker Details
2.3.2 Bruker Major Business
2.3.3 Bruker Metabolic Biomarker Testing Product and Solutions
2.3.4 Bruker Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bruker Recent Developments and Future Plans
2.4 Danaher
2.4.1 Danaher Details
2.4.2 Danaher Major Business
2.4.3 Danaher Metabolic Biomarker Testing Product and Solutions
2.4.4 Danaher Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Danaher Recent Developments and Future Plans
2.5 Waters Corporation
2.5.1 Waters Corporation Details
2.5.2 Waters Corporation Major Business
2.5.3 Waters Corporation Metabolic Biomarker Testing Product and Solutions
2.5.4 Waters Corporation Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Waters Corporation Recent Developments and Future Plans
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business
2.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Product and Solutions
2.6.4 Thermo Fisher Scientific Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.7 Biocrates Life Sciences
2.7.1 Biocrates Life Sciences Details
2.7.2 Biocrates Life Sciences Major Business
2.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Product and Solutions
2.7.4 Biocrates Life Sciences Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biocrates Life Sciences Recent Developments and Future Plans
2.8 Human Metabolome Technologies
2.8.1 Human Metabolome Technologies Details
2.8.2 Human Metabolome Technologies Major Business
2.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Product and Solutions
2.8.4 Human Metabolome Technologies Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Human Metabolome Technologies Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Metabolic Biomarker Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Metabolic Biomarker Testing by Company Revenue
3.2.2 Top 3 Metabolic Biomarker Testing Players Market Share in 2023
3.2.3 Top 6 Metabolic Biomarker Testing Players Market Share in 2023
3.3 Metabolic Biomarker Testing Market: Overall Company Footprint Analysis
3.3.1 Metabolic Biomarker Testing Market: Region Footprint
3.3.2 Metabolic Biomarker Testing Market: Company Product Type Footprint
3.3.3 Metabolic Biomarker Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Technology
4.1 Global Metabolic Biomarker Testing Consumption Value and Market Share by Technology (2019-2024)
4.2 Global Metabolic Biomarker Testing Market Forecast by Technology (2025-2030)
5 Market Size Segment by Application
5.1 Global Metabolic Biomarker Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Metabolic Biomarker Testing Market Forecast by Application (2025-2030)
6 North America
6.1 North America Metabolic Biomarker Testing Consumption Value by Technology (2019-2030)
6.2 North America Metabolic Biomarker Testing Consumption Value by Application (2019-2030)
6.3 North America Metabolic Biomarker Testing Market Size by Country
6.3.1 North America Metabolic Biomarker Testing Consumption Value by Country (2019-2030)
6.3.2 United States Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Metabolic Biomarker Testing Consumption Value by Technology (2019-2030)
7.2 Europe Metabolic Biomarker Testing Consumption Value by Application (2019-2030)
7.3 Europe Metabolic Biomarker Testing Market Size by Country
7.3.1 Europe Metabolic Biomarker Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
7.3.3 France Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Biomarker Testing Consumption Value by Technology (2019-2030)
8.2 Asia-Pacific Metabolic Biomarker Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Region
8.3.1 Asia-Pacific Metabolic Biomarker Testing Consumption Value by Region (2019-2030)
8.3.2 China Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
8.3.5 India Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
9 South America
9.1 South America Metabolic Biomarker Testing Consumption Value by Technology (2019-2030)
9.2 South America Metabolic Biomarker Testing Consumption Value by Application (2019-2030)
9.3 South America Metabolic Biomarker Testing Market Size by Country
9.3.1 South America Metabolic Biomarker Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Biomarker Testing Consumption Value by Technology (2019-2030)
10.2 Middle East & Africa Metabolic Biomarker Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Country
10.3.1 Middle East & Africa Metabolic Biomarker Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Metabolic Biomarker Testing Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Metabolic Biomarker Testing Market Drivers
11.2 Metabolic Biomarker Testing Market Restraints
11.3 Metabolic Biomarker Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Metabolic Biomarker Testing Industry Chain
12.2 Metabolic Biomarker Testing Upstream Analysis
12.3 Metabolic Biomarker Testing Midstream Analysis
12.4 Metabolic Biomarker Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂